StockData

TFA Therapeutics, Inc. (RAJAF) stock

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

TFA Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

TFA Therapeutics's pe ratio was 916.0× on Feb 28, 2025.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Feb 28, 2025916.0×+91.0
2024Dec 31, 2024825.0×–

More TFA Therapeutics figures

See a number that looks wrong?